Consumer Marketing and Education

• Direct-to-Consumer (DTC) Advertising & Marketing
• Compliance Marketing & Education
• Patient Education

February 2008 (Vol. 7, Issue #2)

Executive Summary of Complete Issue
(Click to access and order complete issue)

• Jarvik: A Modern DTC Tragedy
• FDA's Good Reprint Practices Guidance
• Helping Pharma eMarketing "Grow up"
• Understanding the Strategic Value of MSLs
• Prescription Drugs and the Health 2.0 Opportunity

November 2005 (Vol. 4, Issue #10)

• Pharma Marketing Blog a "Must Read"
• DTC Pros and Cons Presented at FDA Hearing
• Predictive Physician Marketing
• GSK Strikes Back with a Grassroots Campaign
• Global Digital Asset Brand Management
• Sales Rep Assessment: Shoot the Messenger, the Message, or Both?

October 2005 (Vol. 4, Issue #9)

• Surveys Say...
• eDetailing: Yesterday, Today and Tomorrow
• Managing Cross Boundary Issues
• Society of Industry Leaders: Help for Investors
• Mobile Medical Reference: An Effective Door Opener for Sales Reps

September 2005 (Vol. 4, Issue #8)

• It's the Science, Stupid!
• cDetailing: Addressing the Consumer Education Gap
• The Evolving Impact of Anti-Spam Legislation on Online Marketers
• Patient Detailing at the Point of Care
• Midwestern eMarketing Values

July/August 2005 (Vol. 4, Issue #7)

• Restrict DTC, but Extend the Patent for New Drugs
• To Ban or Not to Ban DTC, That is the Question
• Marketing the Pharma Industry: The Empire Strikes Back
• Translate Industry Trends into the Optimal Promotional Strategy
• A Call to Action: A Mea Non Culpa by Big Pharma

June 2005 (Vol. 4, Issue #6)

• Transparency is the Word These Days
• Compliance with (Some) New ACCME Rules Not So Easy
• Protecting Your Brand with Anti-Counterfeiting Solutions
• Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
• Drug Risk Survey Results
• A Strategic Approach to CME Offers High Return on Education Investment
• Pharma BloggoSphere Update

May 2005 (Vol. 4, Issue #5)

• A Good Time Was Had by All
• A Proposal for a Drug Risk Advisory System
• Thought-Leader Management: A Challenge Met
• Marketing in the Post-Vioxx Era
• Return on CME: Are Pharma Companies Getting Desired Outcomes?
• Is Pharma Marketing a Lot of BS?

April 2005 (Vol. 4, Issue #4)

• Separation of Church and State
• E-mail Marketing Best Practices for Pharma
• Measuring Marketing Strategy
• Beyond the eDetail: Evolving to Educate
• Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
• Survey Results: Straight-Talking DTC

March 2005 (Vol. 4, Issue #3)

• Give Docs What They Want
• Marketing's Role in Limiting Physician Access and What to Do About It
• Increase Prescription Sales with Smart Tools
• How to Sell a Drug Before it is Approved
• Leverage Health Beliefs to Develop Effective Online Compliance Programs
• Applying FDA Marketing Regulations to Internet Promotions
• Cost-Cutting Strategies for the Pharma Industry

February 2005 (Vol. 4, Issue #2)

• Times They Are A-Changing?
• You May Walk Like a Duck and Quack Like a Duck, But You're No Duck!
• Relationship Marketing Program Management for Pharmaceutical Marketers
• DTC in 2005: Can You Teach Old Dogs New Tricks?
• Numbers, Math and Communicating Risk
• Does the FDA Need to be Overhauled?

January 2005 (Vol. 4, Issue #1)

• Blogging My Way Into 2005!
• Can Health Web Sites Improve Compliance?
• Facilitating Physician Access and Education Through Online Conferencing
• MSL Role in Educational Development
• Motivating & Retaining The MSL: What Makes MSLs Tick
• Managing Medical Science Liaisons From Afar
• A Web-based Therapy Management Program
• Drug Prices, Declining Profits Top Issues for 2005

December 2003 (Vol. 2, Issue #11)

• The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
• Guidelines for Off-label Communications
• Integrating Compliance into Commercial Practices
• Managing Privacy Risks in Your Commercial Practices
• PhRMA Code Succeeding...So Far
• Pharma's Confidence Crisis: A Call for a New Marketing Paradigm?

November 2003 (Vol. 2, Issue #10)

• Balancing Idealistic vs. Realistic CRM Processes
• Developing Win-Win Key Opinion Leader Relationships
• Putting the Customer Back in Customer Relationship Management
• Relationships
• Tailoring CRM Solutions to Your Business Strategy

October 2003 (Vol. 2, Issue #9)

• The Future of eDetailing
• The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
• Optimizing eDetailing ROI
• Why Pharma Can't Ignore eDetailers

September 2003 (Vol. 2, Issue #8)

• Branding Internally: Think Brand, Not Product
• Evolve Your Brand into a Relationship with Consumers and Physicians
• What the Next Generation Physician Wants from Pharma

July 2003 (Vol. 2, Issue #7)

• Out-of-the-Box Marketing: Will It Work for Pharma?
• Patient-Level Data: A New Level of Analysis
• Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness

June 2003 (Vol. 2, Issue #6)

• It's All About Education
• Online CME - A Glass Half-Full or Half-Empty?
• Provider/Pharmaceutical Partnerships - Are They Possible Without Conflict of Interest?
• Responding to the Challenges of Evolving Regulation
• Understanding the Proposed ACCME Standards for Commercial Support

May 2003 (Vol. 2, Issue #5)

• Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
• Ethical Online Practices Build Consumer Trust
• Pharmaceutical Marketing in Texas: look out for state privacy laws!
• Proactive e-Marketing Plan
• Product Branding, e-Marketing May Be Underutilized

April 2003 (Vol. 2, Issue #4)

• e-Marketing at the Point of Care
• Pharma Marketing Network Survey Results
• PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing

March 2003 (Vol. 2, Issue #3)

• Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
• Integrating Online & Offline Marketing: Challenges for Pharma

February 2003 (Vol. 2, Issue #2)

• Quality of Pharma-sponsored Health Information on the Internet

January 2003 (Vol. 2, Issue #1)

• Has DTC Spending Peaked?
• Online and Offline Professional and Consumer Marketing
• Results from FDA Physician Survey on DTC Advertising
• Top Companies, Classes, and Products in the DTC Space

November 2002 (Vol. 1, Issue #9)

• Is Pharma Ready for HIPAA?
• Texas Medical Privacy Act: A Wolf in Sheep's Clothing?

October 2002 (Vol. 1, Issue #8)

• Personalized e-Marketing - How can you create and profit from a customer's lifetime experience?
• What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?

September 2002 (Vol. 1, Issue #7)

• The Absolute, Relative, and Incremental ROI of DTC e-Marketing
• Product Web Sites: Are They Worth It?

February 2002 (Vol. 1, Issue #2)

• Pharmaceutical Compliance with Fair Information Practice Principles